These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16408696)

  • 41. Clinical activity of laromustine (Onrigin™) in hematologic malignancies.
    Alvarado Y; Swords R; Kelly KR; Giles FJ
    Expert Rev Hematol; 2009 Oct; 2(5):481-8. PubMed ID: 21083013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneity of O6-alkylguanine-DNA-alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells.
    Liu L; Lee K; Schupp J; Koç ON; Gerson SL
    Clin Cancer Res; 1998 Feb; 4(2):475-81. PubMed ID: 9516939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
    Bobola MS; Silber JR; Ellenbogen RG; Geyer JR; Blank A; Goff RD
    Clin Cancer Res; 2005 Apr; 11(7):2747-55. PubMed ID: 15814657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo administration of O(6)-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but does inhibit P450-dependent activation of dacarbazine.
    Toft NJ; Sansom OJ; Brookes RA; Arends MJ; Wood M; Margison GP; Winton DJ; Clarke AR
    Carcinogenesis; 2000 Apr; 21(4):593-8. PubMed ID: 10753191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate.
    Dolan ME; Pegg AE; Hora NK; Erickson LC
    Cancer Res; 1988 Jul; 48(13):3603-6. PubMed ID: 2837318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cells.
    Smith SM; Ludeman SM; Wilson LR; Springer JB; Gandhi MC; Dolan ME
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):291-302. PubMed ID: 12845477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial testing of VNP40101M (Cloretazine) by the pediatric preclinical testing program.
    Keir ST; Morton CL; Billups C; Smith MA; Houghton PJ; Gururangan S
    Pediatr Blood Cancer; 2008 Sep; 51(3):439-41. PubMed ID: 18493996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chromosome aberrations: persistence of alkylation damage and modulation by O6-alkylguanine-DNA alkyltransferase.
    Bean CL; Bradt CI; Hill R; Johnson TE; Stallworth M; Galloway SM
    Mutat Res; 1994 May; 307(1):67-81. PubMed ID: 7513826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
    Hansen RJ; Nagasubramanian R; Delaney SM; Cherian MM; Lin S; Kogan SC; Dolan ME
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
    Finch RA; Shyam K; Penketh PG; Sartorelli AC
    Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of codon 160 in the sensitivity of human O6-alkylguanine-DNA alkyltransferase to O6-benzylguanine.
    Xu-Welliver M; Leitão J; Kanugula S; Meehan WJ; Pegg AE
    Biochem Pharmacol; 1999 Oct; 58(8):1279-85. PubMed ID: 10487529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro.
    Turriziani M; Caporaso P; Bonmassar L; Buccisano F; Amadori S; Venditti A; Cantonetti M; D'Atri S; Bonmassar E
    Pharmacol Res; 2006 Apr; 53(4):317-23. PubMed ID: 16412662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acquired resistance to O6-benzylguanine plus chloroethylnitrosoureas in human breast cancer.
    Phillips WP; Gerson SL
    Cancer Chemother Pharmacol; 1999; 44(4):319-26. PubMed ID: 10447580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. O6-benzylguanine and its role in chemotherapy.
    Dolan ME; Pegg AE
    Clin Cancer Res; 1997 Jun; 3(6):837-47. PubMed ID: 9815757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors.
    Dolan ME; Posner M; Karrison T; Radosta J; Steinberg G; Bertucci D; Vujasin L; Ratain MJ
    Clin Cancer Res; 2002 Aug; 8(8):2519-23. PubMed ID: 12171878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of O6-alkylguanine-DNA alkyltransferase in the resistance of mouse spermatogenic cells to O6-alkylating agents.
    Thompson MJ; Abdul-Rahman S; Baker TG; Rafferty JA; Margison GP; Bibby MC
    J Reprod Fertil; 2000 Jul; 119(2):339-46. PubMed ID: 10864847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.
    Wedge SR; Porteous JK; Newlands ES
    Br J Cancer; 1996 Oct; 74(7):1030-6. PubMed ID: 8855970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanine.
    Griffin RJ; Arris CE; Bleasdale C; Boyle FT; Calvert AH; Curtin NJ; Dalby C; Kanugula S; Lembicz NK; Newell DR; Pegg AE; Golding BT
    J Med Chem; 2000 Nov; 43(22):4071-83. PubMed ID: 11063604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mutation of human O6-alkylguanine-DNA alkyltransferase confers resistance to O6-benzylguanine].
    Wan Y; Wu D; Gao H
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):290-3. PubMed ID: 11778552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of glutathione and glutathione S-transferases on DNA interstrand cross-link formation by 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine, the active anticancer moiety generated by laromustine.
    Penketh PG; Patridge E; Shyam K; Baumann RP; Zhu R; Ishiguro K; Sartorelli AC
    Chem Res Toxicol; 2014 Aug; 27(8):1440-9. PubMed ID: 25012050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.